AbbVie (ABBV) EPS (Diluted) (2012 - 2026)
AbbVie's EPS (Diluted) came in at $2.04 for Q2 2026, up 285.2% from $0.53 a year earlier and up 420.7% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EPS (Diluted) (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AbbVie reported EPS (Diluted) of $3.56, up 67.7% year-over-year; for FY2025, it was $2.38, down 1.2% from FY2024.
- EPS (Diluted) has declined in each of the last three years, with a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Going back by year, EPS (Diluted) was $2.41 in FY2024 (-12.0%), $2.74 in FY2023 (-58.8%), $6.66 in FY2022 (+2.5%) and $6.50 in FY2021 (+135.4%).
- The Q2 2026 figure represents the highest quarterly EPS (Diluted) since Q3 2022.
- Year-over-year, EPS (Diluted) increased in 1 of the last six quarters, with growth averaging 16.9%.
- The fastest year-over-year change in EPS (Diluted) over five years came in Q1 2024 (growth of 473.8%), and the weakest in Q1 2023 (a decline of 94.7%).
- Business Quant data shows ABBV's EPS (Diluted) at $0.39 (Q1 2026), $1.02 (Q4 2025) and $0.10 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 4.31 |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 1.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 |
| Mar 31, 2026 | 0.39 |
| Dec 31, 2025 | 1.02 |
| Sep 30, 2025 | 0.10 |
| Jun 30, 2025 | 0.53 |
| Mar 31, 2025 | 0.73 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.88 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.77 |
| Dec 31, 2023 | 0.46 |
| Sep 30, 2023 | 1.00 |
| Jun 30, 2023 | 1.14 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 1.39 |
| Sep 30, 2022 | 2.22 |
| Jun 30, 2022 | 0.52 |
| Mar 31, 2022 | 2.53 |
| Dec 31, 2021 | 2.28 |
| Sep 30, 2021 | 1.79 |
API Access
AbbVie EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();